[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Brazil Osteoporosis Drugs Market 2016 Industry Trends, Survey, Growth and Forecast

March 2017 | 79 pages | ID: B16D8074E77EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies sales (consumption) of Osteoporosis Drugs in Brazil market, focuses on top players, with sales, price, revenue, gross margin and market share for each player, covering
  • Eli Lilly
  • Novartis
  • Pfizer
  • Amgen
  • Merck
  • Novo nordisk
  • Actavis
  • Roche
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Antiresorptive Drugs
  • Anabolic Drugs
Split by applications, this report focuses on sales, market share and growth rate of Osteoporosis Drugs in each application, can be divided into
  • Female
  • Male
Brazil Osteoporosis Drugs Market 2015 Industry Trends, Survey, Growth and Forecast

1 OSTEOPOROSIS DRUGS OVERVIEW

1.1 Product Overview and Scope of Osteoporosis Drugs
1.2 Classification of Osteoporosis Drugs
  1.2.1 Antiresorptive Drugs
  1.2.2 Anabolic Drugs
1.3 Applications of Osteoporosis Drugs
1.4 Brazil Market Size Sales (Volume) and Revenue (Value) of Osteoporosis Drugs (2011-2021)
  1.4.1 Brazil Osteoporosis Drugs Sales and Growth Rate (2011-2021)
  1.4.2 Brazil Osteoporosis Drugs Revenue and Growth Rate (2011-2021)

2 BRAZIL OSTEOPOROSIS DRUGS COMPETITION BY MANUFACTURERS

2.1 Brazil Osteoporosis Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 Brazil Osteoporosis Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 Brazil Osteoporosis Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Osteoporosis Drugs Market Competitive Situation and Trends
  2.4.1 Osteoporosis Drugs Market Concentration Rate
  2.4.2 Osteoporosis Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 BRAZIL OSTEOPOROSIS DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 Brazil Osteoporosis Drugs Sales and Market Share by Type (2011-2016)
3.2 Brazil Osteoporosis Drugs Revenue and Market Share by Type (2011-2016)
3.3 Brazil Osteoporosis Drugs Price by Type (2011-2016)
3.4 Brazil Osteoporosis Drugs Sales Growth Rate by Type (2011-2016)

4 BRAZIL OSTEOPOROSIS DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 Brazil Osteoporosis Drugs Sales and Market Share by Applications (2011-2016)
4.2 Brazil Osteoporosis Drugs Sales Growth Rate by Applications (2011-2016)
4.3 Market Drivers and Opportunities

5 BRAZIL OSTEOPOROSIS DRUGS MANUFACTURERS PROFILESANALYSIS

5.1 Eli Lilly
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Osteoporosis Drugs Product Information
  5.1.3 Eli Lilly Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
  5.1.4 Main BusinessBusiness Overview
5.2Novartis
  5.2.1 Company Basic Information, Manufacturing Base and Competitors
  5.2.2 Osteoporosis Drugs Product Information
  5.2.3 Novartis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
  5.2.4 Main BusinessBusiness Overview
5.3 Pfizer
  5.3.1 Company Basic Information, Manufacturing Base and Competitors
  5.3.2 Osteoporosis Drugs Product Information
  5.3.3 Pfizer Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
  5.3.4 Main BusinessBusiness Overview
5.4 Amgen
  5.4.1 Company Basic Information, Manufacturing Base and Competitors
  5.4.2 Osteoporosis Drugs Product Information
  5.4.3 Amgen Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
  5.4.4 Main BusinessBusiness Overview
5.5 Merck
  5.5.1 Company Basic Information, Manufacturing Base and Competitors
  5.5.2 Osteoporosis Drugs Product Types, Application and Specification
  5.5.3 Merck Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
  5.5.4 Main BusinessBusiness Overview
5.6 Novo nordisk
  5.6.1 Company Basic Information, Manufacturing Base and Competitors
  5.6.2 Osteoporosis Drugs Product Information
  5.6.3 Novo nordisk Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
  5.6.4 Main BusinessBusiness Overview
5.7 Actavis
  5.7.1 Company Basic Information, Manufacturing Base and Competitors
  5.7.2 Osteoporosis Drugs Product Introduction
  5.7.3 Actavis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
  5.7.4 Main BusinessBusiness Overview
5.8 Roche
  5.8.1 Company Basic Information, Manufacturing Base and Competitors
  5.8.2 Osteoporosis Drugs Product Introduction
  5.8.3 Roche Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
  5.8.4 Main BusinessBusiness Overview

6 OSTEOPOROSIS DRUGS MANUFACTURING COST ANALYSIS

6.1 Osteoporosis Drugs Key Raw Materials Analysis
  6.1.1 Key Suppliers of Raw Materials
  6.1.2 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.3 Manufacturing Process Analysis of Osteoporosis Drugs

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Osteoporosis Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORSTRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 DistributorsTraders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology ProgressRisk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer NeedsCustomer Preference Change
9.3 EconomicPolitical Environmental Change

10 BRAZIL OSTEOPOROSIS DRUGS MARKET FORECAST (2016-2021)

10.1 Brazil Osteoporosis Drugs Sales, Revenue Forecast (2016-2021)
10.2 Brazil Osteoporosis Drugs Sales Forecast by Type (2016-2021)
10.3 Brazil Osteoporosis Drugs Sales Forecast by Application (2016-2021)
10.4 Osteoporosis Drugs Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Osteoporosis Drugs (Fosamax)
Table Classification of Osteoporosis Drugs
Figure Brazil Sales Market Share of Osteoporosis Drugs by Types in 2015
Figure Antiresorptive Drugs Picture
Figure Anabolic Drugs Picture
Figure Brazil Sales Market Share of Osteoporosis Drugs by Applications in 2015
Figure Brazil Osteoporosis Drugs Sales (K Unit) and Growth Rate (2011-2021)
Figure Brazil Osteoporosis Drugs Revenue (M USD) and Growth Rate (2011-2021)
Table Brazil Osteoporosis Drugs Sales (K Unit) of Key Manufacturers (2015 and 2016)
Table Brazil Osteoporosis Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Osteoporosis Drugs Sales Share by Manufacturers
Figure 2016 Osteoporosis Drugs Sales Share by Manufacturers
Table Brazil Osteoporosis Drugs Revenue (M USD) by Manufacturers (2015 and 2016)
Table Brazil Osteoporosis Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Brazil Osteoporosis Drugs Revenue Share by Manufacturers
Table 2016 Brazil Osteoporosis Drugs Revenue Share by Manufacturers
Table Brazil Market Osteoporosis Drugs Average Price (USDUnit) of Key Manufacturers (2015 and 2016)
Figure Brazil Market Osteoporosis Drugs Average Price (USDUnit) of Key Manufacturers in 2015
Figure 2015 Osteoporosis Drugs Sales Share by Manufacturers
Table Osteoporosis Drugs Market Share of Top 3 Manufacturers in 2015
Table Osteoporosis Drugs Market Share of Top 5 Manufacturers in 2015
Table Osteoporosis Drugs Market Mergers & Acquisitions, Expansion
Table Brazil Osteoporosis Drugs Sales (K Unit) by Type (2011-2016)
Table Brazil Osteoporosis Drugs Sales Share by Type (2011-2016)
Figure Brazil Osteoporosis Drugs Sales Market Share by Type in 2015
Table Brazil Osteoporosis Drugs Revenue (M USD) and Market Share by Type (2011-2016)
Table Brazil Osteoporosis Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Osteoporosis Drugs by Type (2011-2016)
Table Brazil Osteoporosis Drugs Price (USDUnit) by Types (2011-2016)
Figure Brazil Osteoporosis Drugs Sales Growth Rate by Type (2011-2016)
Table Brazil Osteoporosis Drugs Sales (K Unit) by Applications (2011-2016)
Table Brazil Osteoporosis Drugs Sales Market Share by Applications (2011-2016)
Figure Brazil Osteoporosis Drugs Sales Market Share by Applications in 2015
Table Brazil Osteoporosis Drugs Sales Growth Rate by Applications (2011-2016)
Figure Brazil Osteoporosis Drugs Sales Growth Rate by Applications (2011-2016)
Table Prevalence of Osteoporosis Based on Different Studies in the Brazilian Population
Table Costs in USD of Diagnostic Tests for Osteoporosis
Table Low Bone Density Prevalence According to Brazilian Studies
Table Eli Lilly Basic Information List
Figure Osteoporosis Drugs Product Introduction of Eli Lilly
Table Eli Lilly Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
Figure Eli Lilly Osteoporosis Drugs Revenue Market Share (2015 and 2016)
Figure Main BusinessBusiness of Eli Lilly
Table Novartis Basic Information List
Figure Osteoporosis Drugs Product Picture of Novartis
Table Novartis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
Figure Novartis Osteoporosis Drugs Revenue Market Share (2015 and 2016)
Table Pfizer Basic Information List
Figure Osteoporosis Drugs Product Introduction of Pfizer
Table Pfizer Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
Figure Pfizer Osteoporosis Drugs Revenue Market Share (2015 and 2016)
Figure Main BusinessBusiness Overview of Pfizer
Table Amgen Basic Information List
Figure Osteoporosis Drugs Product Introduction of Amgen
Table Amgen Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
Figure Amgen Osteoporosis Drugs Revenue Market Share (2015 and 2016)
Table Main BusinessBusiness Overview
Table Merck Basic Information List
Figure Osteoporosis Drugs Product Picture of Merck
Table Merck Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
Figure Merck Osteoporosis Drugs Revenue Market Share (2015 and 2016)
Table Novo nordisk Basic Information List
Figure Osteoporosis Drugs Product Picture of Novo nordisk
Table Novo nordisk Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
Figure Novo nordisk Osteoporosis Drugs Revenue Market Share (2015 and 2016)
Figure Main BusinessBusiness Overview
Table Actavis Basic Information List
Table Osteoporosis Drugs Product Introduction
Table Actavis Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
Figure Actavis Osteoporosis Drugs Revenue Market Share (2015 and 2016)
Table Roche Basic Information List
Table Osteoporosis Drugs Product Introduction
Table Roche Osteoporosis Drugs Sales, Revenue, Price and Gross Margin (2015 and 2016)
Figure Roche Osteoporosis Drugs Revenue Market Share (2015 and 2016)
Figure Roche Main BusinessBusiness Overview
Table Key Suppliers of Raw Material
Figure Market Concentration Rate of Global Active Pharmaceutical Ingredient (API) Market in 2015
Figure Manufacturing Cost Structure of Osteoporosis Drugs in 2015
Figure General Manufacturing Process Analysis of Osteoporosis Drugs
Figure Osteoporosis Drugs Industrial Chain Analysis
Table Major Buyers of Osteoporosis Drugs
Figure Marketing Channels of Osteoporosis Drugs
Figure Direct Sales Proportion of Osteoporosis Drugs (2011-2015)
Figure Indirect Sales Proportion of Osteoporosis Drugs (2011-2015)
Figure Direct & Indirect Sales Proportion Forecast of Osteoporosis Drugs (2016-2021)
Figure Brazil Osteoporosis Drugs Price by Companies in 2015 (USDUnit)
Figure Brazil Osteoporosis Drugs Price by Product Types in 2015 (USDUnit)
Figure Brazil Major Brands Market Share of Osteoporosis Drugs in 2015 (Revenue)
Table Target Client in Brazil
Table DistributorsTraders List
Figure Customer Purchase Channels Preference of Osteoporosis Drugs in 2015
Figure Brazil Osteoporosis Drugs Sales (K Unit) and Growth Rate Forecast (2016-2021)
Figure Brazil Osteoporosis Drugs Revenue (M USD) and Growth Rate Forecast (2016-2021)
Table Brazil Osteoporosis Drugs Sales (K Unit) Forecast by Type (2016-2021)
Table Brazil Osteoporosis Drugs Sales (K Unit) Forecast by Application (2016-2021)
Table Brazil Osteoporosis Drugs Price (USDUnit) Forecast (2016-2021)


More Publications